Skip to main navigation menu Skip to main content Skip to site footer

Proceso de atención y prescripción en neumonía adquirida en la comunidad en hospitales universitarios en Colombia

Proceso de atención y prescripción en neumonía adquirida en la comunidad en hospitales universitarios en Colombia




Section
Research article

How to Cite
Martínez CE, Jaimes FA, Montúfar FE, Hincapié GA, Morales Álvaro, Acero R, et al. Proceso de atención y prescripción en neumonía adquirida en la comunidad en hospitales universitarios en Colombia.
rev. colomb. neumol. [Internet]. 2003 Dec. 4 [cited 2025 May 22];15(4):181-9. Disponible en: https://doi.org/10.30789/rcneumologia.v15.n4.2003.1254

Dimensions
PlumX
license
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Carlos Elí Martínez
    Fabián A. Jaimes
      Franco E. Montúfar
        Gustavo A. Hincapié
          Álvaro Morales

            Fabián A. Jaimes,

            Universidad de Antioquia y Hospital San Vicente de Paúl, Medellín.


            Franco E. Montúfar ,

            Hospital Universitario Hernando Moncaleano Perdomo y Universidad Surcolombiana, Neiva.


            Objective: To describe the process of care and prescription practices for CAP patients in tour university hospitals in Colombia. 

            Design: Cohort study. 

            Setting: Four third-level University Hospitals in three Colombian citíes. 

            Patients and Methods: Patients older than 15 years with a diagnosis of CAP during the two years study period. Collection of demographic and clínical status data and management during the first day of consult. Classification in severity groups  according to Fine 's prediction rule. Evaluation of the frequency of use of ancíllary diagnostic tests, antimicrobials prescription and agreement with ATS guidelines, according to severity group and hospital. 

            Results: 734 patients were included, mean age 56 years old, 50.5% males, mean length of stay 8.6 days, 39% Fine 's classes IV to V. Frequency of sputum sampling [overall cohort (between hospitals rank)] was 46% (10 - 67%), chest X-ray 95% (57-100%), blood cultures 34% (O - 63%) and arterial blood gas analysis 71% (10 - 88%). The use of ancíllary diagnostic test had wide variation between hospitals and severity classes, specially for sputum and blood gases. At least 45 different antimicrobial protocols were used in the cohort. Overall agreement between actual prescription and guidelines recommendations was variable (mean 44%, range 22 to 72%) between groups and hospitals, but without significant impact on mortality. 

            Conclusions: There are many differences between actual clinical practice and guidelines for the management of CAP and wide variations between hospitals, but the precise effect of the lack of guideline-adherence on mortality is unclear. 


            Article visits 16 | PDF visits 9


            Downloads

            Download data is not yet available.
            1. Murray CJL, Lopez AD. Mortality by cause tor eigth regions ot the world: Global Burden ot Disease Study. Lancet 1997; 349: 1269 - 1276.
            2. Estadísticas de MINSALUD, 1997. Citado en Comité Nacional Conjunto de Neumonía Adquirida en la Comunidad. Recomendaciones para el diagnóstico, tratamiento y prevención de la neumonía adquirida en la comunidad en adultos. Rev Colomb Neumol 2003; 15 (supl. 3): S1-S42.
            3. Halm EA, Teirstein AS. Management ot community-acquired pneumonia. N Engl J Med 2002; 2039-2045.
            4. American Thoracic Society. Guidelines tor the management ot adults with community-acquired pneumonia. Am J Respir Crit Care Med 2001; 163: 1730-1754.
            5. Bartlett JG, Dovell SF, Mandell LA y cols. Practice guidelines for the management ot community-acquired pneumonia in adults. Clin lntect Dis 200; 31: 347-382.
            6. Pautas de la Sociedad Colombiana de Neumología. Diagnóstico y tratamiento de la Neumonía adquirida en la Comunidad. Rev Colomb Neumol 1995; 7: 104-113.
            7. Jaimes FA, Cepeda NA, Martínez CE, Saavedra C, Trujillo H. Proceso de manejo y prácticas de prescripción en neumonía adquirida en la comunidad en hospitales universitarios en Colombia. Acta Med Col 1998; 23 (Suplemento): 251.
            8. Fine MJ, Auble TE, Yealy DM y cols. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Medi 1997; 336: 243-250.
            9. Robinson E, Ortiz G, Martínez CE. Diagnóstico de la EPOC en la práctica clínica, conocimiento y aplicación de las pautas de diagnóstico. Revista Colombiana de Neumología 2000; 12: 126-131.
            10. Grol R, Dalhuijsen J, Thomas S. Attributes ot clinical guidelines that influence use ot guidelines on clinical practice,observational study. BMJ 1998; 317: 858-861.
            11. Atlas SJ, Benzer TI, Borowsky LH y cols. Sately increasing the proportion ot patients with community-acquired pneumonia treated as outpatients: an interventional lrial. Arch lntern Med 1998; 158: 1350-1356.
            12. Marrie TJ, Lau CY, Wheeler SL y cols. A controlled trial ot a critical pathway tor treatment ot community-acquired pneumonia. JAMA 2000; 283: 749-755.
            13. Gleason PP. Kapoor WN, Stone RA, et al. Medical outcomes an antimicrobial costs with the use ot the American Thoracic Society guidelines tor outpatients with community-acquired pneumonia. JAMA 1997; 278: 32-39.
            14. Laurichesse H, Sotto A, Bonnet E y cols. Pre and In-Hospital management ot community-acquired pneumonia in Southern France, 1998-1999. Eur J Clin Microbio! lntect Dis 20: 770-778.
            15. Feagan BG, Marrie TJ, Lau CY y cols. Treatment and outcomes ot community-acquired pneumonia al Canadian hospitals. CMAJ 2000; 162: 1415-1420.
            16. Luna CM, Famiglietti A, Absi R y cols. Community-acquired pneumonia: etiology, epidemiology and outcome al a teaching hospital in Argentina. Chest 2000; 118: 1344-1354.
            17. Fine MJ, Singe DE, Phelps AL y cols. Differences in length ot hospital stay in patients with community-acquired pneumonia: a prospeclive tour-hospital study. Med Care 1993; 31: 371-380.
            18. Dennis RJ, Pérez A, Rowan K, Londoño D, Metcalfe A y cols.Factores asociados con la mortalidad hospitalaria en pacientes admitidos en cuidados intensivos en Colombia. Arch Bronconeumol 2002: 38: 117-122.
            19. Menendez R, Femando D, Valles JM, Valterra J. lnfluence ot deviation trom guidelines on the outcome of community-acquired pneumonia. Chest 2002; 122: 612-617.
            20. Gleason PP, Meehan TP, Fine MJ y cols. Associations between inilial anlimicrobial therapy and medical outcomes for hospitalizad elderly patients with pneumonia. Arch lntern Med1999; 159: 2562-2572.
            21. Brown RB, lanninni P, Gross P, Kundel M. Impacto ot initial antibiotic choice on clinical outcomes in community-acquired pneumonia. Analysis of a hospital claims-made database. Chest 2003; 123: 1503-1511.
            22. Ritkin WD, Conner D, Silver A, Eichorn A. Comparison ot process and outcomes ot pneumonia care between hospitalists and community-based primary care physicians. Mayo Clin Proc 2002; 77: 1053-1058.
            23. Waterer GW, Combination antibiotic therapy with macrolides in community-acquired pneumonia: more smoke but is there any tire? Chest 2003; 123: 1328-1329.
            24. Comité Nacional Conjunto de Neumonía Adquirida en la Comunidad. Recomendaciones para el diagnóstico, tratamiento y prevención de la neumonía adquirida en la comunidad en adultos. Rev Colomb Neumol 2003; 15 (supl.3): S1-S42.
            25. Nathwani D, Rubinstein E, Barlow G, Davey P. Do guidelines tor community-acquired pneumonia improve the cost-effectiveness of hospital care? Clin lnfect Dis 2001; 32: 728-741.
            26. Finch RG, Low DE. A critica! assessment ot published guidelines and other decision-support systems tor the antibiotic treatment of community-acquired respiratory tract intection. Clin Microbio! lntect 2002; 8 (suppl. 2): 69-91.
            27. Chaparro C, Ortega H, Torres C, Giralda H. Neumonía adquirida en la comunidad. Rev Colomb Neumol 1989; 1: 17-24.
            28. Giralda H, Dueñas R. Neumonías en la Clínica Shaio de Bogotá. Rev Colomb Neumol 1993; 5: 171 .
            29. Morales A, Rodríguez MM, Cepeda O, Contreras RO. Neumonía adquirida en la comunidad,descripción del perfil de 81 casos hospitalizados durante un período de 19 meses en un hospital general de Bogotá. Rev Colomb Neumol 1997; 9: 180-182.
            30. Robledo J, Sierra P, Bedoya F, Londoño A, Porras A y cols.Neumonías adquiridas en la comunidad en adultos: un estudio etiológico prospectivo con énfasis en el diagnóstico. Rev Colomb Neumol 2003; 15: 7-14.
            Sistema OJS 3.4.0.7 - Metabiblioteca |